Electronic Poster Abstracts 2020
DOI: 10.1136/neurintsurg-2020-snis.131
|View full text |Cite
|
Sign up to set email alerts
|

E-098 Mechanical thrombectomy in the extended 24 hour time window for acute ischemic stroke patients with large vessel occlusion

Abstract: ConclusionThe shorter and simpler PREDICT scale was found to be less preferable with EMS provider all-comers, which may be partially due to the mere-exposure cognitive bias effect though this difference persisted in providers who had no prior exposure to either scale. In providers who enrolled multiple patients, there was a statistically insignificant trend towards preference for RACE between their first and last screening.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

2
0
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 0 publications
2
0
0
Order By: Relevance
“…This applies to all patients in our cohort treated ≥ 6-24 h, and even for those patients who would have formally met the study criteria (mRS = 0-2: 20% in our cohort vs. 48% in DAWN and 44% in DEFUSE3). This is in line with a recent single-center analysis by Salam et al (n = 166) where good functional outcome occurred in 24% [17]. The BEST cohort [9], another real-life study, also found worse clinical results of trial-eligible patients when compared to the randomized studies, but these were more favorable than in our cohort (mRS 0-2 = 30%, 14/47); however, the estimated infarct core volumes in BEST were very small (6 ml [0-20]) [9].…”
Section: Prevalence and Outcomesupporting
confidence: 92%
See 1 more Smart Citation
“…This applies to all patients in our cohort treated ≥ 6-24 h, and even for those patients who would have formally met the study criteria (mRS = 0-2: 20% in our cohort vs. 48% in DAWN and 44% in DEFUSE3). This is in line with a recent single-center analysis by Salam et al (n = 166) where good functional outcome occurred in 24% [17]. The BEST cohort [9], another real-life study, also found worse clinical results of trial-eligible patients when compared to the randomized studies, but these were more favorable than in our cohort (mRS 0-2 = 30%, 14/47); however, the estimated infarct core volumes in BEST were very small (6 ml [0-20]) [9].…”
Section: Prevalence and Outcomesupporting
confidence: 92%
“…In line with our results, in a subgroup of those patients with a significantly larger core volume (45.2 ml [37-60]) and thus ineligibility for both trials, the percentage of good outcomes dropped to 24% (8/33) [4]. Within the BEST registry, 36% (16/45) of trial ineligible patients reached a good outcome, but NIHSS on admission (12 [7][8][9][10][11][12][13][14][15][16][17][18]) and core volume (15 ml [0-49]) were much lower compared to our cohort, possibly explained by the high rate (41%) of M2 occlusions.…”
Section: Prevalence and Outcomesupporting
confidence: 86%